- Filed
- May 4, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2026 · Apr 28, 2026 | 33.1M sh |
| Shares Diluted | Q3 2026 · Jan 31, 2026 | 32.94M sh |
| Shares Diluted | Q3 2026 · Jan 31, 2026 | 33.07M sh |
| Shares Diluted | Q3 2026 · Jan 31, 2025 | 33.06M sh |
| Shares Diluted | Q3 2026 · Jan 31, 2025 | 32.96M sh |
| Dividends Paid | Q3 2026 · Jan 31, 2026 | $5.53M |
| Dividends Paid | Q3 2026 · Jan 31, 2025 | $11.34M |
| Capex | Q3 2026 · Jan 31, 2026 | $11.78M |
| Capex | Q3 2026 · Jan 31, 2025 | $8.13M |
| Operating Cash Flow | Q3 2026 · Jan 31, 2026 | −$24.78M |
| Operating Cash Flow | Q3 2026 · Jan 31, 2025 | −$107.67M |
| Short Term Investments | Q3 2026 · Jan 31, 2026 | $48.09M |
| Short Term Investments | Q3 2026 · Apr 30, 2025 | $88.79M |
| Cash And Equivalents | Q3 2026 · Jan 31, 2026 | $129.83M |
| Cash And Equivalents | Q3 2026 · Jan 31, 2025 | $77.69M |
| Stockholders Equity | Q3 2026 · Jan 31, 2026 | $295.38M |
| Stockholders Equity | Q3 2026 · Apr 30, 2025 | $298.13M |
| Current Liabilities | Q3 2026 · Jan 31, 2026 | $553.97M |
| Current Liabilities | Q3 2026 · Apr 30, 2025 | $265.88M |
| Total Liabilities | Q3 2026 · Jan 31, 2026 | $870.72M |
| Total Liabilities | Q3 2026 · Apr 30, 2025 | $543.58M |
| Current Assets | Q3 2026 · Jan 31, 2026 | $1.01B |
| Current Assets | Q3 2026 · Apr 30, 2025 | $631.82M |
| Total Assets | Q3 2026 · Jan 31, 2026 | $1.43B |
| Total Assets | Q3 2026 · Apr 30, 2025 | $1.1B |
| Eps Diluted | Q3 2026 · Jan 31, 2026 | −$0.31 |
| Eps Diluted | Q3 2026 · Jan 31, 2026 | $0.02 |
| Eps Diluted restated | Q3 2026 · Jan 31, 2025 | $0.73 |
| Eps Diluted restated | Q3 2026 · Jan 31, 2025 | $2.50 |
| Eps Basic | Q3 2026 · Jan 31, 2026 | −$0.31 |
| Eps Basic | Q3 2026 · Jan 31, 2026 | $0.02 |
| Eps Basic restated | Q3 2026 · Jan 31, 2025 | $0.74 |
| Eps Basic restated | Q3 2026 · Jan 31, 2025 | $2.56 |
| Net Income | Q3 2026 · Jan 31, 2026 | −$10.27M |
| Net Income | Q3 2026 · Jan 31, 2026 | $795K |
| Net Income restated | Q3 2026 · Jan 31, 2025 | $24.06M |
| Net Income restated | Q3 2026 · Jan 31, 2025 | $81.94M |
| Operating Income | Q3 2026 · Jan 31, 2026 | $4.99M |
| Operating Income | Q3 2026 · Jan 31, 2026 | $18.69M |
| Operating Income restated | Q3 2026 · Jan 31, 2025 | $35.24M |
| Operating Income restated | Q3 2026 · Jan 31, 2025 | $119.23M |
| Revenue | Q3 2026 · Jan 31, 2026 | $518.49M |
| Revenue | Q3 2026 · Jan 31, 2026 | $1.46B |
| Revenue restated | Q3 2026 · Jan 31, 2025 | $471.26M |
| Revenue restated | Q3 2026 · Jan 31, 2025 | $1.27B |